Mutual-fund company’s change of course in March comes after it had cut the value of these investments in the first two months of the year Fidelity Investments reversed course in March, marking up many of the stakes in closely held technology companies it had previously cut, including a biotech startup that was subsequently acquired at a large premium. The mutual-fund company late Friday released valuation estimates as of March 31 for its holdings in various funds. Fidelity wrote up the value of software firm Domo Inc. by 68% after marking it down 29% in February. Stemcentrx Inc., the cancer-drug maker that AbbVie Inc. said this past week that it would...

http://www.wsj.com/articles/fidelity-in-reversal-raises-value-of-many-tech-startups-1462041176